Qube Research & Technologies (QRT)’s Compugen CGEN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26K	Buy	+12,197	New	+$23.7K	﹤0.01%	3252
2024 Q3	–	Sell	-29,516	Closed	-$49.6K	–	3398
2024 Q2	$49.6K	Sell	29,516 -25,420	-46%	-$53K	﹤0.01%	2743
2024 Q1	$142K	Buy	54,936 +54,630	+17,853%	+$127K	﹤0.01%	3178
2023 Q4	$606	Buy	306 +200	+189%	+$175	﹤0.01%	3905
2023 Q3	$99	Buy	+106	New	+$117	﹤0.01%	3766
2022 Q2	–	Sell	-26,513	Closed	-$85K	–	2556
2022 Q1	$85K	Buy	+26,513	New	+$89.5K	﹤0.01%	2103
2021 Q3	–	Sell	-14,794	Closed	-$122K	–	2255
2021 Q2	$122K	Buy	+14,794	New	+$120K	﹤0.01%	1908
2021 Q1	–	Sell	-13,386	Closed	-$162K	–	1961
2020 Q4	$162K	Sell	13,386 -30,545	-70%	-$421K	﹤0.01%	1571
2020 Q3	$714K	Buy	43,931 +2,705	+7%	+$44.3K	0.01%	905
2020 Q2	$619K	Buy	41,226 +27,975	+211%	+$378K	0.01%	1030
2020 Q1	$96K	Buy	+13,251	New	+$104K	﹤0.01%	977

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CGEN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Compugen (CGEN) in Q1 2026: 12,197 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #3252 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in CGEN as recently as Q2 2024.

Qube Research & Technologies (QRT) first reported a position in CGEN in Q1 2020 and has held it in 11 quarters since. The position peaked at $714K in Q3 2020. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

Qube Research & Technologies (QRT) held 12,197 shares of Compugen worth $26K as of Q1 2026.
Compugen was a new Qube Research & Technologies (QRT) position in Q1 2026.
Compugen made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3252 holding.
Qube Research & Technologies (QRT) first reported a position in Compugen in Q1 2020 and has held it in 11 quarters since.
Qube Research & Technologies (QRT)'s Compugen position peaked at $714K in Q3 2020.
78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.